GranBio is a pioneering industrial biotechnology company whose purpose is to develop innovative solutions to revert the impacts of man-made climate change due to the emission of greenhouse gases. GranBio's mission is to make economically feasible the deployment on large scale of cellulose carbon for the production of biofuels, biochemicals, and advanced renewable materials as one of the alternatives to the intensive use of fossil carbon.
Created in June 2011, GranBio operates the first commercial scale plant of cellulosic ethanol or second generation ethanol (2G) in the Southern Hemisphere, an unprecedented project in Brazilian industry. The biorefinery - named Bioflex 1 - converts biomass from sugarcane residue, straw and bagasse into 2G ethanol and lignin.
The production of biofuel made from sugarcane straw, a raw material that was discarded or burned in canebrake, places the company among the most sustainable companies of the sector on the planet, and GranBio's 2G ethanol is the biofuel produced on a commercial scale with less carbon footprint.
BioFlex 1 is proof of concept of biomass potential on a commercial scale. In addition to BioFlex 1, GranBio holds two semi-commercial scale biorefineries in the United States that demonstrate GranBio technology for biochemicals and nanocellulose with more than 200 patents registered in the area of renewable materials.
Innovation in Bioenergy
GranBio is controlled by GranInvestimentos S.A., the holding company of the Gradin family, with 85% of the share capital, and BNDESPar, the BNDES’ subsidiary and ownership interest manager, is its shareholder with 15% of the share capital.